Clinical Trial Update: Hematological Clozapine Monitoring With a Point-of-care Device (CHEMPAQ)

View source ↗

Summary

This document reports a completed clinical trial evaluating a point-of-care hematological monitoring device (CHEMPAQ) for clozapine safety in schizophrenia. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Clozapine (Clozapine)

Snippet

Sponsor: University of Aarhus | Conditions: Schizophrenia | Status: COMPLETED